odSafety.com, Inc. Enters Biotech Arena with Revolutionary Lyme Disease Product;

[Guest guest]

eFoodSafety.com, Inc. Enters Biotech Arena with Revolutionary Lyme Disease

Product; Human Clinical Trials Currently Underway

4/4/2006 9:50:00 AM EST

Gruden, President/CEO of eFoodSafety.com, Inc. (OTCBB:EFSF),

announced today that Knock-Out Technologies, Ltd., a wholly-owned subsidiary of

eFoodSafety.com, Inc., has developed a safe, natural, ingestible product that is

believed to eradicate Lyme disease.

Bucks County Clinical Research, Inc., (BCCR) (http://bccrinc.com/), an FDA

clinical facility, is conducting the testing of the Lyme disease product under

the direction of J. , D.O., FAAP, Executive Director of BCCR,

and M. Goldfarb, M.D., FACS, Medical Director of Research & Development

of BCCR, a Director of eFoodSafety.com, Inc., and President of MedElite,

Inc., a wholly-owned subsidiary of eFoodSafety.com, Inc.

The protocol guidelines for patient enrollment criteria include patients who

have known, laboratory documented Lyme disease and have undergone multiple

courses of conventional treatment, but have all relapsed.

In 2003, the National Center for Infectious Diseases (NCID) estimated annual

costs for treatment of Lyme disease at $60 million a year in the United

States alone.

" We have pursued human clinical trials to prove our groundbreaking

technology will be effective in eradicating Lyme disease in patients seeking a

permanent solution for their chronic symptoms. We also plan on commencing

testing in

the near future on a broader spectrum of Lyme disease patients, those who

have been newly diagnosed and not responsive to current conventional

treatment, " stated Mrs. Gruden.

Lyme disease is caused by the bacterium Borrelia burgdorferi and is

transmitted to humans by the bite of infected blacklegged ticks. Typical

symptoms

include fever, headache, fatigue, and a characteristic skin rash called

erythema

migrans. If left untreated, infection can spread to joints, the heart, and

the nervous system. Lyme disease is diagnosed based on symptoms, physical

findings (e.g., bullseye rash), and the possibility of exposure to infected

ticks; laboratory testing is helpful in the later stages of disease. The ticks

that transmit Lyme disease can occasionally transmit other tick-borne diseases

as well (Division of Vector-Borne Infectious Diseases) (DVBID); National

Center for Infectious Diseases (NCID); Centers for Disease Control and

Prevention;

http://www.cdc.gov).

About eFoodSafety.com, Inc.

eFoodSafety.com, Inc. is dedicated to improving food and health conditions

around the world through its innovative technologies. The company's Knock-Out

Technologies, Ltd. subsidiary has developed an environmentally safe

sporicidal product formulated entirely of food-grade components that eradicates

anthrax and a germicidal product, Big 6 Plus - EPA Reg. No. 82723-1 that kills

six

major bacteria: E-coli, Listeria, Pseudomonas, Salmonella, Staphylococcus,

and Streptococcus, Avian Influenza, and Black Mold. The sporicidal product has

completed its final efficacy laboratory study requisite for EPA registration.

In the study, it eradicated both Clostridium Sporogenes and Bacillus Subtilis

with 100% efficacy on both hard and porous surfaces. The company's MedElite,

Inc. subsidiary distributes clinically proven products to physicians who

then prescribe the products for their patients. It is the exclusive U.S. and

worldwide distributor of the Talsyn-CI/bid Scar Cream that has been

clinically proven to facilitate and improve the appearance, redness and strength

of

scars (www.talsyn.com). The company is also is a distributor for

Cinnergen, a non-prescription liquid whole food nutritional supplement that

promotes

healthy glucose metabolism (www.cinnergen.com), and Trimmendous, a weight

loss formula focusing on the body's 24-hour metabolic processes. The company

has recently entered into a joint venture agreement with CK41 Direct, Inc.

to launch an anti-acne skin care system, with a branded name and celebrity

spokesperson to-be-announced in the near future.

Safe Harbor Forward-Looking Statements

Statements contained in this release that are not strictly historical are

" forward-looking " statements within the meaning of Section 27A of the

Securities Act of 1933 as amended, and Section 21E of the Securities Exchange

Act of

1934, as amended. The forward-looking statements are made based on information

available as of the date hereof, and the company assumes no obligation to

update such forward-looking statements. Editors and investors are cautioned

that such forward-looking statements invoke risk and uncertainties and the

company's actual results may differ from these forward-looking statements. Such

risks and uncertainties include but are not limited to demand for the company's

products and services, our ability to continue to develop markets, general

economic conditions, our ability to secure additional financing for the

company and other factors that may be more fully described in reports to

shareholders and periodic filings with the Securities and Exchange Commission.

CONTACT:

Redwood Consultants, LLC Jens Dalsgaard, 415-884-0348

© 2006 Genetic Engineering News, All Rights Reserved

http://www.genengnews.com/news/bnitem.aspx?name=104031

(mailto:mmi@...)